Pathology of COPD 2009

  • Upload
    zakwan

  • View
    219

  • Download
    0

Embed Size (px)

Citation preview

  • 8/14/2019 Pathology of COPD 2009

    1/67

    DR:MIE ALI ALI MOHAMED

    Chronic Obstructive

    Pulmonary Diseases (COPD(

  • 8/14/2019 Pathology of COPD 2009

    2/67

    Chronic Obstructive PulmonaryDiseases (COPD(

    A group of pulmonary diseases

    characterized by increasedresistance to air flow due to partialor complete obstruction at any level.

  • 8/14/2019 Pathology of COPD 2009

    3/67

  • 8/14/2019 Pathology of COPD 2009

    4/67

    (l) Chronic Bronchitis

    It is persistent productive cough (cough ofsputum) for at least 3 consecutive

    months in at least 2 consecutive years.

  • 8/14/2019 Pathology of COPD 2009

    5/67

    )l) Chronic Bronchitis

    Causes:Due to chronic

    irritation of the bronchial mucosaby:

    1- Cigarette smoking.

    2- Atmospheric pollution

    3- Chronic inflammation of upperrespiratory tract, tonsils or mouth.

    Pathology: Occur in middle-aged men.

  • 8/14/2019 Pathology of COPD 2009

    6/67

  • 8/14/2019 Pathology of COPD 2009

    7/67

    )1(Chronic Bronchitis

    N/E: Bronchial mucosa appears thick, opaque andcovered by excess mucous.

    M/E:

    1) Epitheluim:a- Bronchi:- Goblet cell hyperplasia and decreased number of

    ciliated cells.

    - Squamous metaplasia and dysplasia.b- Brochioles:Goblet cells metaplasia

  • 8/14/2019 Pathology of COPD 2009

    8/67

    )1(Chronic Bronchitis

    2) Subepithelial Tissue:chronic inflammatory cell

    infiltrations.

    Bronchial mucous glands arehyperplastic, hyperactive withprogressive fibrosis.

  • 8/14/2019 Pathology of COPD 2009

    9/67

  • 8/14/2019 Pathology of COPD 2009

    10/67

  • 8/14/2019 Pathology of COPD 2009

    11/67

    )1(Chronic Bronchitis

    Complications:1- Centrilobular emphysema.

    2- Bronchopneumonia.

    3- Bronchogenic carcinoma.4- Chronic hypoxaemia resulting in persistent

    pulmonary vasoconstriction, pulmonaryhypertension and cor pulmonale.

    5- Cardiac failure.

  • 8/14/2019 Pathology of COPD 2009

    12/67

    )3(Emphysema

    Permanent dilatation of air spaces distal to theterminal bronchioles accompanied bydamage of their walls.

    i.e. respiratory bronchioles, alveolar ducts andalveoli (respiratory acinus).

    Incidence:

    The commonest chronic lung disease. Itoccurs more in males from 40-60years of age.

  • 8/14/2019 Pathology of COPD 2009

    13/67

  • 8/14/2019 Pathology of COPD 2009

    14/67

    )3(Emphysema

    A- Centriacinar (Centrilobular):It involves respiratory bronchiole (central part of

    acinus).

    Pathogenesis:

    It is related to cigarette smoking and it is explainedby the following theories:

  • 8/14/2019 Pathology of COPD 2009

    15/67

    11--Elastase - antielastase imbalance theoryElastase - antielastase imbalance theory

    Smoking weakens the walls of air

    spaces by increasing elastase andinhibiting antielastase

  • 8/14/2019 Pathology of COPD 2009

    16/67

    22((Direct Damage TheoryDirect Damage Theory::

    The walls of air spaces are injured

    directly by toxic substances ofcigarette smoking.

  • 8/14/2019 Pathology of COPD 2009

    17/67

    33((Chronic Bronchitis theoryChronic Bronchitis theory::

    a- Smoking recruits neutrophils andmacrophages and stimulates the release of

    elastase from them.b- It increases mucus secretion leading to

    mucus plugs which partially obstruct thebronchi and Terminal bronchioles. Duringexpiration the air is entrapped andincreases gradually the intraluminalpressure.

  • 8/14/2019 Pathology of COPD 2009

    18/67

  • 8/14/2019 Pathology of COPD 2009

    19/67

  • 8/14/2019 Pathology of COPD 2009

    20/67

    B- Panacinar( Panlobular):It involves the whole acinus and occurs more in

    old females.

    Pathogenesis: Related to inheriteddeficiency of antielastase ( 1 antitrypsin) in thepatient's blood. Therefore the action of elastase

    secreted from neutrophils and macrophagesbecomes unopposed.

    (3) Emphysema(3) Emphysema

  • 8/14/2019 Pathology of COPD 2009

    21/67

    N/E of emphysema:

    A- Centriacinar emphysema:Upper zones of the lung lobes are first affected.

    The lungs are moderately enlarged.

    The affection is mainly centrally located in theacinus (RB)

    C/S:- Enlarged air spaces, which are seen in

    clusters at the center of the lung acinus.

  • 8/14/2019 Pathology of COPD 2009

    22/67

    N/E of emphysema:

    B- Panacinar emphysema:l) Barrel shaped chest:

    The chest wall takes a fixed exaggerated inspiration

    position:a- The anteroposterior diameter increases to equal the

    transverse. The sternum is pushed forward andmoderate kyphosis occurs.

    b- The ribs, costal cartilages and the intercostal spacesare horizontal.

    c- The subcostal angle is wide.

  • 8/14/2019 Pathology of COPD 2009

    23/67

  • 8/14/2019 Pathology of COPD 2009

    24/67

    N/E of emphysema:

    2) Lungs: Lower zones of lung lobes are first affected.

    The lungs are voluminous and very light.

    They are pale and dry . The surface is smooth and presents the

    indentations of ribs.

    Lungs have a feathery feeling and pit on pressure

    (due to loss of elastic tissue).

  • 8/14/2019 Pathology of COPD 2009

    25/67

    Large bullae project on the surface in the poorlysupported parts (along apices, anterior margin andfree edge of base).

    A bulla is an emphysematous space of more than 1cm in diameter, it is semitranslucent with paper thinned walls.

  • 8/14/2019 Pathology of COPD 2009

    26/67

  • 8/14/2019 Pathology of COPD 2009

    27/67

  • 8/14/2019 Pathology of COPD 2009

    28/67

    Centrilobularemphysema

  • 8/14/2019 Pathology of COPD 2009

    29/67

  • 8/14/2019 Pathology of COPD 2009

    30/67

    Centrilobular

    emphysema

  • 8/14/2019 Pathology of COPD 2009

    31/67

    Emphysema

    M/E:A) Centrilobular emphysema

    Dilated respiratory bronchioles (R.B.) with normalA.D. and alveoli.

    B) Panacinar emphysema.

    l) Alveoli are:

    Few in number, increased in size, distorted inshape.

  • 8/14/2019 Pathology of COPD 2009

    32/67

    Emphysema

    2) Interalveolar septa: Thin and in advanced stages, alveolar septa

    rupture.

    The interalveolar capillaries are compressed bydilated air spaces.

  • 8/14/2019 Pathology of COPD 2009

    33/67

  • 8/14/2019 Pathology of COPD 2009

    34/67

    http://www.microscopyu.com/galleries/pathology/emphysemalarge.htmlhttp://www.microscopyu.com/galleries/pathology/emphysema.html
  • 8/14/2019 Pathology of COPD 2009

    35/67

    Emphysema

    Complications:l) Respiratory system:Ch. bronchitis.Interstitial emphysema.Spontaneous pneumothoraxRespiratory failure.

    2) C. V. S.:pulmonary hypertension and right sided heart

    failure.

  • 8/14/2019 Pathology of COPD 2009

    36/67

    Other types of Emphysema

    I- Obstructive Hyperinflation (emphysema)

    II- Compensatory Hyperinflation(Emphysema)

    III- Senile (Atrophic) hyperintlation(emphysema)

    IV- Interstitial Emphysema:

  • 8/14/2019 Pathology of COPD 2009

    37/67

    Pneumonitis

    Inflammation of lung tissue.

    Classification1) Bacteria1:

    - Lobar pneumonia.

    - Bronchopneumonia.2) Primary Atypical Peneumonitis

    3) Loeffler's Pnueumonia

    4) Granuloma

    5) Lipid Pneumonia6) Irradiation Pneumonia

  • 8/14/2019 Pathology of COPD 2009

    38/67

    Lobar Pneumonia

    Acute bacterial infection involving at least an entire lobe oflung (due to streptococcus pneumonia in 95 % of cases)

    Incidence:

    It predominates in middle-aged males.

    Method of infection:By inhalation. (droplet infection)

  • 8/14/2019 Pathology of COPD 2009

    39/67

    Pathogenesis:1- Exogenous or endogenous pneumococci are

    inhaled to reach alveoli.2- They settle into lower lung lobes and one or both

    sides are involved.3- Micro-organisms in alveoli produce an

    inflammatory reaction with fluid exudate.4- it pass from one alveolus to another through

    inter- alveolar pores to involve the whole lobe andthe pleura.

    Lobar PneumoniaLobar Pneumonia

  • 8/14/2019 Pathology of COPD 2009

    40/67

    5- The fluid together with the cellular exudate expelair away from the alveoli producing a firm airlesslobe leading to consolidation (hepatisation) of the

    affected lobe.

    Pathology:Sero-fibrinous inflammation of lung that passes in

    the following stages.

    Lobar PneumoniaLobar Pneumonia

  • 8/14/2019 Pathology of COPD 2009

    41/67

    l) Stage of congestion (1-2 days):N/E:1- The involved lobe is:

    - Enlarged, dark red and heavy.- Wet sponge in consistancy.

    2- Cut surface: exudes a frothy serous fluids

    M/E:1- Inter-alveolar capillaries are congested

    2- Alveoli contain oedema, some air, bacteria andscattered neutrophils.

    Lobar PneumoniaLobar Pneumonia

  • 8/14/2019 Pathology of COPD 2009

    42/67

    2) Stage of red hepatization (2 - 4 days):N /E:1-The affected lobe:

    - Enlarged, red and heavy.- firm and airless (like the liver)

    2- Cut surface: dry and granular.

    3- Serofibrinous pleurisy.

    4- Hilar L. N. are enlarged (inflamed).

    Lobar PneumoniaLobar Pneumonia

  • 8/14/2019 Pathology of COPD 2009

    43/67

    M/E:1- Inter-alveolar cappillaries still congested.

    2- The alveoli are filled with exudate formed of fibrin

    network entangling in its meshes excessneutrophils, R.B.Cs., few macrophages withbacteria.

    Lobar PneumoniaLobar Pneumonia

  • 8/14/2019 Pathology of COPD 2009

    44/67

    3) Stage of grey Hepatization (4-8 days) :

    N/E:1. Affected lobe: Enlarged and grey in colour.

    Firm and airless (like the liver)

    2. Cut surface: dry and granular.

    3. Fibrinous pleurisy.

    4. Hilar lymph nodes are enlarged.

    Lobar PneumoniaLobar Pneumonia

  • 8/14/2019 Pathology of COPD 2009

    45/67

    M/E:1-Inter-alveolar capillaries: less congested.

    2- Alveoli contain:

    - Fibrin threads in the center (fibrin retracts give a

    clear zone adjacent to alv. walls).-Most inflammatory cells are dead and progressively

    disintegrat.

    -Most micro-organisms are dead and disappear

    -Macrophages increase in number.3- Fibrinous pleurisy

    Lobar PneumoniaLobar Pneumonia

  • 8/14/2019 Pathology of COPD 2009

    46/67

    4) Stage of Resolution (8 - 21 days):Occur in uncomplicated cases:

    - Exudate within the alveoli is gradually liquified by

    fibrinolytic enzymes of inflammatory cells. It isreabsorbed through lymphatics or blood vessels orremoved by macrophages and rarely coughed up.

    Lobar PneumoniaLobar Pneumonia

  • 8/14/2019 Pathology of COPD 2009

    47/67

    N/E:1- The affected lobe:

    - The size decrease gradually until it becomes normal withrestoration of the normal color.

    - The consistency becomes as wet sponge and is finallyairful.

    2- Cut surface: Wet, smooth and exudes a frothy creamyfluid.

    3- Pleurisy resolves.

    4- Hilar lymphadenitis disappears.

    Lobar PneumoniaLobar Pneumonia

  • 8/14/2019 Pathology of COPD 2009

    48/67

  • 8/14/2019 Pathology of COPD 2009

    49/67

  • 8/14/2019 Pathology of COPD 2009

    50/67

  • 8/14/2019 Pathology of COPD 2009

    51/67

  • 8/14/2019 Pathology of COPD 2009

    52/67

    M/E:Mild or no congestion of inter-alveolar capillaries.

    The alveoli contain liquified inflammatory

    exudate and increased number of macrophages.Lastly the affected lobe appears normal.

    Lobar PneumoniaLobar Pneumonia

  • 8/14/2019 Pathology of COPD 2009

    53/67

  • 8/14/2019 Pathology of COPD 2009

    54/67

  • 8/14/2019 Pathology of COPD 2009

    55/67

    1) Pulmonary (in the lung): Delayed resolution. Fibrosis, Lung abscess and gangrene.

    2) Extrapulmonary (outside lungs): Spread of infection to pleura

    Direct, lymphatic and Blood spread Toxaemia.

    Clinical course:7-9 days and terminates by crisis (sudden improvement).

    Complications of Lobar PneumoniaComplications of Lobar Pneumonia

  • 8/14/2019 Pathology of COPD 2009

    56/67

    Bacterial BronchopneumoniaBacterial Bronchopneumonia

    Acute bacterial infection of the bronchioles and thesurrounding alveoli.

    Aetiology:

    1) Staphylococcus aureus.2) Streptococcus pyogens.

    3) Pnoumococous.

    4) haemophilus influenza

    Mode of infection: by inhalation.

  • 8/14/2019 Pathology of COPD 2009

    57/67

    Types:1) Primary bronchopneumonia: Due to 1ry (exogenous) invaders.

    Extremes of age.2) Secondary bronchopneumonia:

    Due to 2ry (endogenous) invaders whichcomplicate other diseases.

    Bacterial BronchopneumoniaBacterial Bronchopneumonia

    B t i l B h iB t i l B h i

  • 8/14/2019 Pathology of COPD 2009

    58/67

    PathologyAcute suppurative inflammation of bronchioles andsurrounding alveoli.

    N/E: Multiple patches of consolidation, distributed

    through several lung lobes or one lobe. Commonly present in lower lobes (basal) of both

    lungs (bilateral) They are better felt than seen.

    Bacterial BronchopneumoniaBacterial Bronchopneumonia

  • 8/14/2019 Pathology of COPD 2009

    59/67

    They are centered around the bronchioles.

    Cut surface of a patch is slightly elevated, dry,granular, gery red to yellow and exudes pus on

    pressure. Areas between the patches are either normal,

    collapsed or emphysematous.

    Pleurisy is not a marked feature, as the patches do

    not usually contact the pleura.

    Bacterial BronchopneumoniaBacterial Bronchopneumonia

  • 8/14/2019 Pathology of COPD 2009

    60/67

  • 8/14/2019 Pathology of COPD 2009

    61/67

  • 8/14/2019 Pathology of COPD 2009

    62/67

  • 8/14/2019 Pathology of COPD 2009

    63/67

    M/E: Patchy affection of bronchioles and

    surrounding alveoli of acute suppurativebronchiolitis at different stages ofdevelopment. . The surrounding alveoli are filled with

    pus rich in inflammatory cells and pus

    cells. Interalveolar septa are acutely inflamed.

    Bacterial BronchopneumoniaBacterial Bronchopneumonia

  • 8/14/2019 Pathology of COPD 2009

    64/67

  • 8/14/2019 Pathology of COPD 2009

    65/67

    Complications:Complications:1. In lung:

    Lung abscess and gangrene.

    Lung fibrosis, leading to pulmonary hypertension andright-sided head failure.

    Bonchiectasis.

    2. In pleura:

    Empyema.

    Bacterial BronchopneumoniaBacterial Bronchopneumonia

  • 8/14/2019 Pathology of COPD 2009

    66/67

    3. Outside the lungs:a- Spread of infection:- Direct.- Lymphatic spread.- Blood spread.

    b- Due to toxaemia:

    Clinical course: 2-3 weeks and terminates by lysis.

    Bacterial BronchopneumoniaBacterial Bronchopneumonia

  • 8/14/2019 Pathology of COPD 2009

    67/67

    Thankyo

    u